Cargando…
A novel fusion gene PLEKHA6‐NTRK3 in langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is the most common histiocytosis with constitutive activation of the RAS–RAF–MEK–ERK (MAPKinase) cell signaling pathway. We analyzed 89 cases of BRAF and MAP2K1 mutations by Sanger sequencing, of which 18 cases showed that these two gene mutations are negative. Wh...
Autores principales: | Cai, Jiaoyang, Huang, Xia, Yin, Minzhi, Pan, Ci, Song, Lili, Zhan, Zhiyan, Chen, Jing, Gao, Yijin, Tang, Jingyan, Li, Yanxin, Shen, Shuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587734/ https://www.ncbi.nlm.nih.gov/pubmed/30098202 http://dx.doi.org/10.1002/ijc.31636 |
Ejemplares similares
-
WW, PH and C-Terminal Domains Cooperate to Direct the Subcellular Localizations of PLEKHA5, PLEKHA6 and PLEKHA7
por: Sluysmans, Sophie, et al.
Publicado: (2021) -
Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing
por: Chan, Warren H., et al.
Publicado: (2020) -
Hepatic Langerhans cell histiocytosis: A review
por: Fu, Zhiyan, et al.
Publicado: (2021) -
Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011) -
Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018)